BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 31912210)

  • 1. Systematic review of the clinical spectrum of CASPR2 antibody syndrome.
    Boyko M; Au KLK; Casault C; de Robles P; Pfeffer G
    J Neurol; 2020 Apr; 267(4):1137-1146. PubMed ID: 31912210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures.
    Joubert B; Saint-Martin M; Noraz N; Picard G; Rogemond V; Ducray F; Desestret V; Psimaras D; Delattre JY; Antoine JC; Honnorat J
    JAMA Neurol; 2016 Sep; 73(9):1115-24. PubMed ID: 27428927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspr2 antibody limbic encephalitis is associated with Hashimoto thyroiditis and thymoma.
    Lee CH; Lin JJ; Lin KJ; Chang BL; Hsieh HY; Chen WH; Lin KL; Fung HC; Wu T
    J Neurol Sci; 2014 Jun; 341(1-2):36-40. PubMed ID: 24726720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study.
    Qin X; Yang H; Zhu F; Wang Q; Shan W
    Front Immunol; 2021; 12():652864. PubMed ID: 34054814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies.
    Jia Y; Shi H; Ye J; Wang Y
    Clin Neurol Neurosurg; 2020 Oct; 197():106187. PubMed ID: 32911250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical spectrum of Caspr2 antibody-associated disease.
    van Sonderen A; Ariño H; Petit-Pedrol M; Leypoldt F; Körtvélyessy P; Wandinger KP; Lancaster E; Wirtz PW; Schreurs MW; Sillevis Smitt PA; Graus F; Dalmau J; Titulaer MJ
    Neurology; 2016 Aug; 87(5):521-8. PubMed ID: 27371488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report.
    Zhang L; Lu Q; Guan HZ; Mei JH; Ren HT; Liu MS; Peng B; Cui LY
    BMC Neurol; 2016 Mar; 16():37. PubMed ID: 26983964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features.
    Muñiz-Castrillo S; Joubert B; Elsensohn MH; Pinto AL; Saint-Martin M; Vogrig A; Picard G; Rogemond V; Dubois V; Tamouza R; Maucort-Boulch D; Honnorat J
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1076-1084. PubMed ID: 32651251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of 28 cases of anti
    Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encephalopathy with upper body hypertonia and myoclonus in patient with systemic lupus erythematosus and anti-CASPR2.
    Castro A; Romeu JC; Geraldes R; Pereira da Silva JA
    Lupus; 2017 Jan; 26(1):84-87. PubMed ID: 27432809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome.
    Bien CG; Mirzadjanova Z; Baumgartner C; Onugoren MD; Grunwald T; Holtkamp M; Isenmann S; Kermer P; Melzer N; Naumann M; Riepe M; Schäbitz WR; von Oertzen TJ; von Podewils F; Rauschka H; May TW
    Eur J Neurol; 2017 Jan; 24(1):175-186. PubMed ID: 27786401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis.
    Gövert F; Abrante L; Becktepe J; Balint B; Ganos C; Hofstadt-van Oy U; Krogias C; Varley J; Irani SR; Paneva S; Titulaer MJ; de Vries JM; Boon AJW; Schreurs MWJ; Joubert B; Honnorat J; Vogrig A; Ariño H; Sabater L; Dalmau J; Scotton S; Jacob S; Melzer N; Bien CG; Geis C; Lewerenz J; Prüss H; Wandinger KP; Deuschl G; Leypoldt F
    Brain; 2023 Feb; 146(2):657-667. PubMed ID: 35875984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review.
    Sapana T; Li W; Tian F; Yan W; Dou B; Hua S; Zhuo Z
    Front Immunol; 2023; 14():1274672. PubMed ID: 38077387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct phenotypes in a cohort of anti-CASPR2 associated neurological syndromes.
    Moura J; Samões R; Cardoso M; Sousa AP; Damásio J; Marinho A; Carneiro P; Neves E; Silva AM; Santos E
    Clin Neurol Neurosurg; 2023 Nov; 234():107994. PubMed ID: 37797365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.
    Montojo MT; Petit-Pedrol M; Graus F; Dalmau J
    Neurologia; 2015 Jun; 30(5):295-301. PubMed ID: 24485651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous muscle activity, Morvan's syndrome and limbic encephalitis: ionic or non ionic disorders?
    Serratrice G; Serratrice J
    Acta Myol; 2011 Jun; 30(1):32-3. PubMed ID: 21842591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
    Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
    Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations of patients with CASPR2 antibodies.
    Sunwoo JS; Lee ST; Byun JI; Moon J; Shin JW; Jeong DE; Lee GH; Jeong SH; Shin YW; Jung KH; Lee DY; Jeon D; Jung KY; Kim M; Lee SK; Chu K
    J Neuroimmunol; 2015 Apr; 281():17-22. PubMed ID: 25867463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.
    Kannoth S; Nambiar V; Gopinath S; Anandakuttan A; Mathai A; Rajan PK
    Neurol Sci; 2018 Mar; 39(3):455-460. PubMed ID: 29264691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia.
    Lancaster E; Huijbers MG; Bar V; Boronat A; Wong A; Martinez-Hernandez E; Wilson C; Jacobs D; Lai M; Walker RW; Graus F; Bataller L; Illa I; Markx S; Strauss KA; Peles E; Scherer SS; Dalmau J
    Ann Neurol; 2011 Feb; 69(2):303-11. PubMed ID: 21387375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.